One Health Seminar: One Health in a Changing World: From Guelph to Global Pandemic Preparedness
Jonathan Heeney, Professor at the University of Cambridge, is CSO and founder of DIOSynVax; “Digitally Immune Optimised Synthetic Vaccines”, a clinical stage Biotech based in Cambridge UK. DIOSynVax’s Computational Vaccine antigen technology leverages AI to design broadly protective vaccine antigen payloads to protect from high consequence diseases of humans and animals. The company has advanced vaccine candidates for seasonal, universal and pre-pandemic (H5Nx, H1N1, H7N2, etc) Influenza, pan-Beta Coronaviruses and a Mpox vaccine carrying broad Filovirus and Arenavirus payloads that...